India: Merck Divests 6 Brands To Zydus Healthcare Limited
Last Updated: 27 January 2017


United States pharmaceutical giant Merck & Co., Inc. (known as Merck Sharp & Dohme (MSD) outside the United States and Canada), through its subsidiaries, divested its 6 brands to Zydus Cadila's wholly owned subsidiary Zydus Healthcare Limited. Pharmaceutical products in the segment of men's and women's health, wound management and cardiovascular therapy were sold under these brands.

In addition to the sale of brand names, Organon India Private Limited, an Indian subsidiary company of Merck & Co., Inc. /MSD, assigned manufacturing know-how, distribution and commercialization rights for 3 of the brands sold as part of the deal.

Press coverage relating to this transaction available at Business Standard, Economic Times, Live Mint and Pharma Biz.


We, at Nishith Desai Associates, acted as the Indian legal and regulatory counsel to MSD.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Press Releases from this Firm
Recent Content from this Firm
By Aditya Shukla
By Shweta Sahu, Ashish Kabra, Vyapak Desai
By Jaideep Reddy, Ruchi Biyani, Vaibhav Parikh
By Kshama Loya Modani, Sahil Kanuga, Vyapak Desai
By Atikant Kaur Sahni, Payel Chatterjee, Pratibha Jain, Gowree Gokhale
By Ajay Solanki, Vikram Shroff
By Nishith Desai Associates
By Aarushi Jain, Vivek Kathpalia
By Anandapadmanabhan Unnikrishnan, Swati Sharma, Arjun Gupta, M.S. Ananth, Sahil Kanuga
By Siddharth Ratho, Vyapak Desai
Font Size: